Drug

■ Core developers who participated in the event of the AI ​​'Alpha Fold 2' in Google Deep Mind established a brand new drug development startup. Attracting $ 50 million in seed investmentSuccessful. Within the...

In a breakthrough for AI-powered drug discovery, Insilico Medicine announced positive Phase IIa results for its novel drug ISM001-055, designed to treat Idiopathic Pulmonary Fibrosis (IPF). This small molecule, developed using Insilico’s proprietary generative...

Since Insilico Medicine developed a drug for idiopathic pulmonary fibrosis (IPF) using generative AI, there's been a growing excitement about how this technology could change drug discovery. Traditional methods are slow and expensive, so...

As generative AI evolves, it moves beyond deciphering human language to mastering the intricate languages of biology and chemistry. Consider DNA as a detailed script, a 3-billion-letter sequence that guides our body's functions and...

Using AI to streamline drug discovery is exploding. Researchers are deploying machine-learning...

In an unprecedented advancement in drug discovery, Zapata Computing, Inc., alongside Insilico Medicine, the University of Toronto, and St. Jude Kid's Research Hospital, has showcased the remarkable potential of quantum-enhanced generative AI. This collaboration...

Researchers on the University of Cambridge have developed an AI-driven platform that dramatically accelerates the prediction of chemical reactions, a vital step in drug discovery. Moving away from traditional trial-and-error methods, this revolutionary approach...

Biotech, pharmaceutical and life sciences firms all hope AI will streamline drug development and make it more efficient, and 38% have already adopted the technology, in response to Deloitte. QuantHealth goals to participate with...